Cargando…

Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis

There are very few reports about the intake of nutrients for the development or progression of non-alcoholic steatohepatitis (NASH). The aim of this study was to identify the dietary habits and the nutrient intake in patients with NASH, in comparison to chronic hepatitis C (HCV)-related patients. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Federico, Alessandro, Dallio, Marcello, Caprio, Giuseppe Gerardo, Gravina, Antonietta Gerarda, Picascia, Desiree, Masarone, Mario, Persico, Marcello, Loguercio, Carmela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691691/ https://www.ncbi.nlm.nih.gov/pubmed/28956816 http://dx.doi.org/10.3390/nu9101074

Ejemplares similares

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
por: Masarone, Mario, et al.
Publicado: (2018)

Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2018)

Corrigendum to “Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease”
por: Masarone, Mario, et al.
Publicado: (2021)

Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives
por: Dallio, Marcello, et al.
Publicado: (2021)

The Bisphenol A Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease
por: Federico, Alessandro, et al.
Publicado: (2020)

The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
por: Federico, Alessandro, et al.
Publicado: (2021)

Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease
por: Dallio, Marcello, et al.
Publicado: (2019)

Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
por: Federico, Alessandro, et al.
Publicado: (2019)

Coeliac disease and C virus-related chronic hepatitis: a non association
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2012)

PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial
por: Dallio, Marcello, et al.
Publicado: (2021)

Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2020)

Skin Adverse Events During Dual and Triple Therapy for HCV-Related Cirrhosis
por: Federico, Alessandro, et al.
Publicado: (2014)

Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota
por: Morgillo, Floriana, et al.
Publicado: (2018)

From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention
por: Motta, Benedetta Maria, et al.
Publicado: (2023)

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis
por: FEDERICO, ALESSANDRO, et al.
Publicado: (2015)

Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study
por: Federico, Alessandro, et al.
Publicado: (2015)

NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome
por: Rosato, Valerio, et al.
Publicado: (2019)

Secondary Extramedullary Plasmacytoma of the Duodenum: An Unusual Endoscopic Presentation
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2013)

The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials
por: Izzo, Carmine, et al.
Publicado: (2021)

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
por: Federico, Alessandro, et al.
Publicado: (2017)

A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn’s Ileitis Following the Suspension of Ursodeoxycholic Acid
por: Romeo, Mario, et al.
Publicado: (2022)

Cirrhosis and frailty assessment in elderly patients: A paradoxical result
por: Federico, Alessandro, et al.
Publicado: (2020)

AF.86 THE ANALYSIS OF ALCOHOL CONSUMPTION DURING THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ITALIAN LOCKDOWN
por: Romeo, M., et al.
Publicado: (2021)

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

Just Drink a Glass of Water? Effects of Bicarbonate–Sulfate–Calcium–Magnesium Water on the Gut–Liver Axis
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2022)

Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
por: Belli, Valentina, et al.
Publicado: (2017)

Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression
por: Dallio, Marcello, et al.
Publicado: (2021)

Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2021)

Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage
por: Masarone, Mario, et al.
Publicado: (2017)

The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2023)

“Non alcoholic fatty liver disease and eNOS dysfunction in humans”
por: Persico, Marcello, et al.
Publicado: (2017)

Correction to: “Non alcoholic fatty liver disease and eNOS dysfunction in humans”
por: Persico, Marcello, et al.
Publicado: (2017)

Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab
por: Martini, Giulia, et al.
Publicado: (2022)

Helicobacter pylori and extragastric diseases: A review
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2018)

Extra-Gastric Manifestations of Helicobacter pylori Infection
por: Gravina, Antonietta G., et al.
Publicado: (2020)

Viral hepatitis: Milestones, unresolved issues, and future goals
por: Torre, Pietro, et al.
Publicado: (2021)

Country-Wide HCV Elimination Strategies Need to Reach Older Patients in the General Population: The Italian Experience
por: Torre, Pietro, et al.
Publicado: (2023)

Postoperative Changes in Fecal Bacterial Communities and Fermentation Products in Obese Patients Undergoing Bilio-Intestinal Bypass
por: Patrone, Vania, et al.
Publicado: (2016)

The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report
por: Lebano, Rita, et al.
Publicado: (2014)

Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives
por: Pennisi, Grazia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oifhe35g0mlplsr9ielar80puq